Anaplastic Large Cell Lymphomas
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schwab, 1982, . Production of a monoclonal antibody specific for Hodgkin and Reed-Sternberg cells of Hodgkins disease and a subset of normal lymphoid cells., Nature, 299, 65, 10.1038/299065a0
Stein, 1985, . The expression of the Hodgkins disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells., Blood, 66, 848, 10.1182/blood.V66.4.848.848
Kadin, 1986, . Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy., Blood, 68, 1042, 10.1182/blood.V68.5.1042.1042
Stansfeld, 1988, . Updated Kiel classification for lymphomas., Lancet, 1, 292, 10.1016/S0140-6736(88)90367-4
Harris, 1994, . A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group., Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361
Rimokh, 1989, . A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma)., Br J Haematol, 71, 31, 10.1111/j.1365-2141.1989.tb06270.x
Kaneko, 1989, . A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis., Blood, 73, 806, 10.1182/blood.V73.3.806.806
Morris, 1994, . Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkins lymphoma., Science, 263, 1281, 10.1126/science.8122112
Pittaluga, 1997, . The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23ALK rearrangements., Am J Pathol, 151, 343
Matsuyama, 2011, . miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma., Blood, 118, 6881, 10.1182/blood-2011-05-354654
Savage, 2008, . ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project., Blood, 111, 5496, 10.1182/blood-2008-01-134270
Savage, 2004, . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification., Ann Oncol, 15, 1467, 10.1093/annonc/mdh392
Vose, 2008, International peripheral T-cell and natural killerT-cell lymphoma study: pathology findings and clinical outcomes., J Clin Oncol, 26, 4124, 10.1200/JCO.2008.16.4558
Falini, 1999, . ALK lymphoma: clinico-pathological findings and outcome., Blood, 93, 2697
Mathas, 2009, . Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma., Proc Natl Acad Sci U S A, 106, 5831, 10.1073/pnas.0900912106
Trumper, 1998, . Detection of the t(2;5)-associated NPMALK fusion cDNA in peripheral blood cells of healthy individuals., Br J Haematol, 103, 1138, 10.1046/j.1365-2141.1998.01097.x
Maes, 2001, . The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells., Am J Pathol, 158, 2185, 10.1016/S0002-9440(10)64690-1
Lamant, 2010, . Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases., Haematologica, 95, 449, 10.3324/haematol.2009.015024
Bayle, 1999, . Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases., Br J Haematol, 104, 680, 10.1046/j.1365-2141.1999.01238.x
Fraga, 1995, . Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance., Am J Clin Pathol, 103, 82, 10.1093/ajcp/103.1.82
Gascoyne, 1999, . Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma., Blood, 93, 3913, 10.1182/blood.V93.11.3913
Li, 2008, Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy., Med Res Rev, 28, 372, 10.1002/med.20109
Chen, 2013, Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin., Onco Targets Ther, 7, 45
Kadin, 2008, . Primary cutaneous ALCL with phosphorylatedactivated cytoplasmic ALK and novel phenotype: EMAMUC1, cutaneous lymphocyte antigen negative., Am J Surg Pathol, 32, 1421, 10.1097/PAS.0b013e3181648d6d
Oschlies, 2013, . ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study., Haematologica, 98, 50, 10.3324/haematol.2012.065664
Attygalle, 2014, . Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology., Histopathology, 64, 171, 10.1111/his.12251
Benharroch, 1998, . ALK-positive lymphoma: a single disease with a broad spectrum of morphology., Blood, 91, 2076, 10.1182/blood.V91.6.2076
Pileri, 1990, . Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30Ki-1 with a high content of reactive histiocytes)., Histopathology, 16, 383, 10.1111/j.1365-2559.1990.tb01143.x
Kinney, 1993, . A small-cell-predominant variant of primary Ki-1 (CD30) T-cell lymphoma., Am J Surg Pathol, 17, 859, 10.1097/00000478-199309000-00001
Vassallo, 2006, . ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkins lymphoma: report of 10 cases., Am J Surg Pathol, 30, 223, 10.1097/01.pas.0000179123.66748.c2
Nakamura, 1997, . Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPMALK) expression., Am J Surg Pathol, 21, 1420, 10.1097/00000478-199712000-00004
Chan, 1990, Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma., Am J Surg Pathol, 14, 983, 10.1097/00000478-199010000-00013
Foss, 1996, . Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules., Blood, 88, 4005, 10.1182/blood.V88.10.4005.bloodjournal88104005
Wellmann, 2000, . Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large cell lymphomas (ALCL)., Blood, 96, 398, 10.1182/blood.V96.2.398.014k46_398_404
Dunphy, 2006, Pediatric CD56 anaplastic large cell lymphoma: a review of the literature., Arch Pathol Lab Med, 130, 1859, 10.5858/2006-130-1859-PCALCL
Rosso, 1990, . Anaplastic large cell lymphoma, CD30Ki-1 positive, expressing the CD15Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkins disease., Virchows Arch A Pathol Anat Histopathol, 416, 229, 10.1007/BF01678982
Feldman, 2010, . PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus., Mod Pathol, 23, 593, 10.1038/modpathol.2010.4
Juco, 2003, . Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry., Am J Clin Pathol, 119, 205, 10.1309/HEFL7KC435KFWEX8
Zhang, 2013, . Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma., Int J Clin Exp Pathol, 6, 798
Venkataraman, 2013, . Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival., Blood, 121, 1795, 10.1182/blood-2012-06-439455
Delsol, 1997, . A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation., Blood, 89, 1483, 10.1182/blood.V89.5.1483
Soda, 2007, . Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer., Nature, 448, 561, 10.1038/nature05945
Chen, 2008, . Oncogenic mutations of ALK kinase in neuroblastoma., Nature, 455, 971, 10.1038/nature07399
Griffin, 1999, . Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors., Cancer Res, 59, 2776
de Leval, 2009, . Molecular classification of T-cell lymphomas., Crit Rev Oncol Hematol, 72, 125, 10.1016/j.critrevonc.2009.01.002
Lamant, 1999, . A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation., Blood, 93, 3088, 10.1182/blood.V93.9.3088.409k30_3088_3095
Touriol, 2000, . Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)., Blood, 95, 3204, 10.1182/blood.V95.10.3204
Tort, 2001, . Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma., Lab Invest, 81, 419, 10.1038/labinvest.3780249
Damm-Welk, 2009, . Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation., Br J Haematol, 146, 306, 10.1111/j.1365-2141.2009.07754.x
Feldman, 2013, . Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma., Genes Chromosomes Cancer, 52, 1097, 10.1002/gcc.22104
Salaverria, 2008, . Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas., Br J Haematol, 140, 516, 10.1111/j.1365-2141.2007.06924.x
Tartari, 2008, . Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase., J Biol Chem, 283, 3743, 10.1074/jbc.M706067200
Iwahara, 1997, . Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system., Oncogene, 14, 439, 10.1038/sj.onc.1200849
Souttou, 2001, . Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway., J Biol Chem, 276, 9526, 10.1074/jbc.M007333200
Morris, 1997, . ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkins lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)., Oncogene, 14, 2175, 10.1038/sj.onc.1201062
Amin, 2007, Pathobiology of ALK anaplastic large-cell lymphoma., Blood, 110, 2259, 10.1182/blood-2007-04-060715
Bai, 1998, . Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity., Mol Cell Biol, 18, 6951, 10.1128/MCB.18.12.6951
Kuefer, 1997, . Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice., Blood, 90, 2901, 10.1182/blood.V90.8.2901
Chiarle, 2003, . NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors., Blood, 101, 1919, 10.1182/blood-2002-05-1343
Zhang, 2013, . The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4() T lymphocytes., Am J Pathol, 183, 1971, 10.1016/j.ajpath.2013.08.030
Kinney, 2011, Anaplastic large cell lymphoma: twenty-five years of discovery., Arch Pathol Lab Med, 135, 19, 10.5858/2010-0507-RAR.1
Webb, 2009, . Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy., Expert Rev Anticancer Ther, 9, 331, 10.1586/14737140.9.3.331
Chiarle, 2005, . Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target., Nat Med, 11, 623, 10.1038/nm1249
Hamedani, 2014, . Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK() anaplastic large cell lymphoma., Leuk Res, 38, 503, 10.1016/j.leukres.2013.12.027
Amin, 2004, . Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma., Oncogene, 23, 5426, 10.1038/sj.onc.1207703
Amin, 2003, . Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma., Oncogene, 22, 5399, 10.1038/sj.onc.1206849
Lai, 2005, . Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma., Hum Pathol, 36, 939, 10.1016/j.humpath.2005.07.011
Tabbo, 2013, . Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma., Curr Opin Hematol, 20, 374, 10.1097/MOH.0b013e3283623c07
Piva, 2006, . Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes., J Clin Invest, 116, 3171, 10.1172/JCI29401
Laimer, 2012, . PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas., Nat Med, 18, 1699, 10.1038/nm.2966
Shiota, 1995, . Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPMALK: a distinct clinicopathologic entity., Blood, 86, 1954, 10.1182/blood.V86.5.1954.bloodjournal8651954
Shiota, 1996, The clinicopathological features of anaplastic large cell lymphomas expressing p80NPMALK., Leuk Lymphoma, 23, 25, 10.3109/10428199609054798
Sciallis, 2012, . Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders., Mod Pathol, 25, 983, 10.1038/modpathol.2012.38
Wang, 2014, . The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck., Oral Surg Oral Med Oral Pathol Oral Radiol, 117, 96, 10.1016/j.oooo.2013.10.002
Roden, 2008, . Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder., Mod Pathol, 21, 455, 10.1038/modpathol.3801024
Popplewell, 2011, . Primary anaplastic large-cell lymphoma associated with breast implants., Leuk Lymphoma, 52, 1481, 10.3109/10428194.2011.574755
Miranda, 2014, . Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients., J Clin Oncol, 32, 114, 10.1200/JCO.2013.52.7911
Nguyen, 2013, . Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary., J Clin Oncol, 31, e443, 10.1200/JCO.2012.46.7910
Feldman, 2009, . Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas., Leukemia, 23, 574, 10.1038/leu.2008.320
Parrilla Castillar, 2014, . ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes., Blood, 124, 1473, 10.1182/blood-2014-04-571091
Bovio, 2008, The expression of myeloid antigens CD13 andor CD33 is a marker of ALK anaplastic large cell lymphomas., Am J Clin Pathol, 130, 628, 10.1309/PLN1NA4QB2PC1CMQ
Asano, 2006, . Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkins lymphoma: a clinicopathologic study., J Clin Oncol, 24, 4626, 10.1200/JCO.2006.06.5342
Feldman, 2011, . Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively-parallel genomic sequencing., Blood, 117, 915, 10.1182/blood-2010-08-303305
Wada, 2011, . Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies., Mod Pathol, 24, 596, 10.1038/modpathol.2010.225
Karai, 2013, . Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis., Am J Surg Pathol, 37, 1173, 10.1097/PAS.0b013e318282d01e
Pham-Ledard, 2010, . IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases., J Invest Dermatol, 130, 816, 10.1038/jid.2009.314
Kiran, 2013, . The significance of MUM1IRF4 protein expression and IRF4 translocation of CD30() cutaneous T-cell lymphoproliferative disorders: a study of 53 cases., Leuk Res, 37, 396, 10.1016/j.leukres.2012.12.001
Somja, 2014, . Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly., Virchows Arch, 464, 735
Vasmatzis, 2012, . Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas., Blood, 120, 2280, 10.1182/blood-2012-03-419937
Scott, 2012, . TBL1XR1TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma., Blood, 119, 4949, 10.1182/blood-2012-02-414441
Zettl, 2004, . Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations., Am J Pathol, 164, 1837, 10.1016/S0002-9440(10)63742-X
Boi, 2013, . PRDM1BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma., Blood, 122, 2683, 10.1182/blood-2013-04-497933
Aoyama, 2001, . Molecular cloning and characterization of a novel dual specificity phosphatase, LMW-DSP2, that lacks the cdc25 homology domain., J Biol Chem, 276, 27575, 10.1074/jbc.M100408200
Li, 2014, . The phosphatase JKAPDUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck., Nat Commun, 5, 3618, 10.1038/ncomms4618
Alonso, 2002, . Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)., J Biol Chem, 277, 5524, 10.1074/jbc.M107653200
Chen, 2002, . The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway., J Biol Chem, 277, 36592, 10.1074/jbc.M200453200
Shen, 2001, . Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1., Proc Natl Acad Sci U S A, 98, 13613, 10.1073/pnas.231499098
Sekine, 2006, . Regulation of STAT3-mediated signaling by LMW-DSP2., Oncogene, 25, 5801, 10.1038/sj.onc.1209578
Sekine, 2007, . DUSP22LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118., Oncogene, 26, 6038, 10.1038/sj.onc.1210426
Agnelli, 2012, . Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma., Blood, 120, 1274, 10.1182/blood-2012-01-405555
Piccaluga, 2013, . Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study., J Clin Oncol, 31, 3019, 10.1200/JCO.2012.42.5611
Iqbal, 2014, . Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma., Blood, 123, 2915, 10.1182/blood-2013-11-536359
Willemze, 2005, . WHO-EORTC classification for cutaneous lymphomas., Blood, 105, 3768, 10.1182/blood-2004-09-3502
Willemze, 1993, Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment., J Am Acad Dermatol, 28, 973, 10.1016/0190-9622(93)70140-O
Laharanne, 2010, . Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes., J Invest Dermatol, 130, 1707, 10.1038/jid.2010.8
Bekkenk, 2000, . Primary and secondary cutaneous CD30() lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment., Blood, 95, 3653, 10.1182/blood.V95.12.3653
Liu, 2003, . CD30 cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma., J Am Acad Dermatol, 49, 1049, 10.1016/S0190-9622(03)02484-8
Kummer, 1997, . Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype., J Invest Dermatol, 109, 636, 10.1111/1523-1747.ep12337633
Boulland, 2000, . Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins., Histopathology, 36, 136, 10.1046/j.1365-2559.2000.00799.x
de Bruin, 1993, . Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype., Histopathology, 23, 127, 10.1111/j.1365-2559.1993.tb00470.x
Csikesz, 2013, . Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22., J Invest Dermatol, 133, 1680, 10.1038/jid.2013.22
Mao, 2003, . Genetic alterations in primary cutaneous CD30 anaplastic large cell lymphoma., Genes Chromosomes Cancer, 37, 176, 10.1002/gcc.10184
Campbell, 2003, Chemokines in the systemic organization of immunity., Immunol Rev, 195, 58, 10.1034/j.1600-065X.2003.00067.x
Zlotnik, 2000, Chemokines: a new classification system and their role in immunity., Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X
van Kester, 2010, . Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators., J Invest Dermatol, 130, 563, 10.1038/jid.2009.270
Yagi, 1996, . Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma., J Invest Dermatol, 107, 827, 10.1111/1523-1747.ep12330845
Kleinhans, 2003, . Functional expression of the eotaxin receptor CCR3 in CD30 cutaneous T-cell lymphoma., Blood, 101, 1487, 10.1182/blood-2002-02-0475
Zoi-Toli, 2000, . Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL., Br J Dermatol, 143, 313, 10.1046/j.1365-2133.2000.03656.x
Lohoff, 2004, . Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4() Th cells., J Exp Med, 200, 247, 10.1084/jem.20040182
Durkop, 2003, . Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation., J Pathol, 200, 229, 10.1002/path.1351